AMRUTANJAN493.35

Amrutanjan Health Care Limited

· Pharma & Health
AnnualQuarterly₹ CrorePeersJAGSNPHARMNGLFINESIGACHILINCOLNSYNCOMFTHEMISMEDHESTERBIOMcap ₹1,426 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue from Operations421.2451.8502.6511.5
Other Income16.917.717.617.0
Total Income438.2469.5520.1528.4
Expenses
+ Cost of Materials Consumed103.4100.6106.4110.9
+ Purchases of Stock-in-Trade106.3123.2140.6145.5
+ Changes in Inventories2.2-0.6-2.7-7.2
+ Employee Benefit Expense48.359.163.865.4
+ Finance Costs0.20.20.20.2
+ Depreciation & Amortisation6.16.56.36.7
+ Other Expenses109.9111.3118.7123.4
Total Expenses376.2400.4433.4444.9
EBITDA51.258.275.773.5
EBIT45.251.769.466.8
Profit
PBT before Exceptional Items61.969.186.783.5
+ Exceptional Items0.00.0-8.9-10.9
Pretax Income61.969.177.972.7
+ Current Tax15.918.320.018.7
+ Deferred Tax1.00.00.00.0
Tax Expense17.018.320.018.7
Net Income45.050.857.954.0
+ Net Income — Continuing Ops45.050.857.954.0
+ Other Comprehensive Income0.2-0.8-0.1-0.4
Total Comprehensive Income45.150.057.853.5
Per Share
Basic EPS15.5617.5820.0318.67
Diluted EPS15.5617.5820.0318.67
Other Comprehensive Income — detail
+ Other Comprehensive Income-0.8-0.1-0.4
+ Items NOT to be Reclassified to P&L0.2-1.1-0.2-0.6
+ Tax on Items NOT to be Reclassified-0.3-0.0-0.1
+ Tax on Items NOT to be Reclassified — alt tag0.1
Per Share — as-filed variants
Basic EPS — Continuing Operations15.5617.5820.0318.67
Diluted EPS — Continuing Operations15.5617.5820.0318.67
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit209.4228.6258.2262.2
Gross Margin %49.7150.6051.3851.27
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)61.969.186.783.5
− Exceptional Items (reconciliation)0.00.0-8.9-10.9
Net Income Adj (tax-effected)45.050.864.562.1
EPS Adj15.5617.5822.3121.47
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value1.001.001.001.00
Paid Up Equity Capital2.92.92.92.9
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.